A 'healthy baby': The double imperative of preimplantation genetic diagnosis.
This article reports from a study exploring the social processes, meanings and institutions that frame and produce 'ethical problems' and clinical dilemmas for practitioners, scientists and others working in the specialty of preimplantation genetic diagnosis (PGD). A major topic in the data was that, in contrast to IVF, the aim of PGD is to transfer to the woman's womb only those embryos likely to be unaffected by serious genetic disorders; that is, to produce 'healthy babies'. Staff described the complex processes through which embryos in each treatment cycle must meet a double imperative: they must be judged viable by embryologists and 'unaffected' by geneticists. In this article, we focus on some of the ethical, social and occupational issues for staff ensuing from PGD's double imperative.
Ehrich
Kathryn
K
Centre for Biomedicine & Society, King's College London, Strand, London, UK. Kathryn.Ehrich@kcl.ac.uk
Williams
Clare
C
D001291:Attitude of Health Personnel; D003657:Decision Making; D004626:Embryology / Q000941:ethics*; D005260:Female; D005307:Fertilization in Vitro; D005820:Genetic Testing / Q000941:ethics*; D006801:Humans; D011247:Pregnancy; D019836:Preimplantation Diagnosis / Q000941:ethics* / Q000523:psychology*; D036301:Qualitative Research